AI startup Nucleai has immuno-oncology treatment failures in its sightsIsraeli company Nucleai is putting artificial intelligence to work to discover why so many cancer patients don’t respond Share XAI startup Nucleai has immuno-oncology treatment failures in its sightshttps://pharmaphorum.com/news/ai-startup-nucleai-has-immuno-oncology-treatment-failures-in-its-sights/
